022-49717220

marketing@valiantlabs.in

Corporate Announcements: BSE | NSE

Cart

Disclosures

Notice of Board Meetings

FY 2023-2024

Board Meeting dated November 6, 2023

Board Meeting dated February 9, 2024

FY 2024-2025

Board Meeting dated May 14, 2024

Board Meeting dated August 12, 2024

Board Meeting dated November 12, 2024

Board Meeting dated February 7, 2025

FY 2025- 2026

Board Meeting dated May 20, 2025

Board Meeting dated July 09, 2025

Board Meeting dated August 08, 2025

Shareholding Pattern

FY 2023-2024

Shareholding Pattern as on 30-09-2023

Shareholding Pattern as on 31-12-2023

Shareholding Pattern as on 31-03-2024

FY 2024-2025

Shareholding Pattern as on 30-06-2024

Shareholding Pattern as on 30-09-2024

Shareholding Pattern as on 31-12-2024

Shareholding Pattern as on 31-03-2025

FY 2025-2026

Shareholding Pattern as on 30-06-2025

Corporate Governance

FY 2023-2024

Corporate Governance Report for the quarter ended 31-12-2023

Corporate Governance Report for the quarter ended 31-03-2024

FY 2024-2025

Corporate Governance Report for the quarter ended 30-06-2024

Corporate Governance Report for the quarter ended 30-09-2024

Corporate Governance Report for the quarter ended 31-12-2024

Integrated Filing for the quarter ended 31-03-2025

FY 2025-2026

Integrated Filing for the quarter ended 30-06-2025

Closure of Trading Window

FY 2023-2024

Intimation of Closure of Trading window_06.10.2023

Intimation of Closure of Trading window_31.12.2023

Intimation of Closure of Trading window_31.03.2024

FY 2024-25

Intimation of Closure of Trading window_30.06.2024

Intimation of Closure of Trading Window_30.09.2024

Intimation of Closure of Trading Window_31.12.2024

Intimation of Closure of Trading Window_31.03.2025

Intimation of Closure of Trading Window_30.06.2025

Newspaper Publications

FY 2023-2024

Audited Standalone and Consolidated Financials for quarter ended 30-09-2023

Audited Standalone and Consolidated Financials for quarter ended 31-12-2023

Audited Standalone and Consolidated Financials for quarter and year ended 31-03-2024

FY 2024-2025

Audited Standalone and Consolidated Financials for the quarter ended 30-06-2024

Audited Standalone and Consolidated Financials for the quarter ended 30-09-2024

Audited Standalone and Consolidated Financial Results for the quarter ended 31.12.2024

Audited Standalone and Consolidated Financial Results for the quarter and year ended 31.03.2025

FY 2025-2026

Audited Standalone and Consolidated Financial Results for the quarter and year ended 30.06.2025

Credit Ratings

Credit Rating dated 27-11-2023

Credit Rating dated 21-02-2024

Credit Rating dated 06-04-2024


Credit Rating dated 23-08-2024

Credit Rating dated 18-02-2025

Credit Rating dated 25-06-2025

Monitoring Agency Report

For the Quarter ended on 31-12-2023

For the Quarter ended on 31-03-2024

For the Quarter ended on 30-06-2024

For the quarter ended on 30-09-2024

Deviation and Variations

For the Quarter ended on 31-12-2023

For the Quarter ended on 31-03-2024

For the Quarter ended on 30-06-2024

For the quarter ended on 30-09-2024

Annual Return

Annual Secretarial Compliance Report

FY 2023-2024

FY 2024-2025

Postal Ballot

2023-24

Postal Ballot Notice


Newspaper Publication

E Voting Results and Scrutinizer's Report

2024-25

Postal Ballot Notice 

Newspaper Publication

E- Voting Results and Scrutinizer's Report

2023-24

Report on Related Party Transactions for the half year ended 31-03-2024

2024-25

Report on Related Party Transactions for the half year ended 30-09-2024

Report on Related Party Transactions for the half year ended 31-03-2025

Other Disclosures on Stock Exchange

Intimation of the Acquisition

Resignation of Company Secretary


Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for quarter ended March 31,2024

Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for quarter ended December 31,2023

Certificate under Regulation 7(3) of SEBI LODR for year ended March 31, 2024

Certificate under Regulation 40(9) of SEBI (LODR) for year ended March 31, 2024

Notice of AGM_2023-2024

Certificate under Regulation 74 (5) of SEBI (Depositories and Participants) Regulations, 2018 for quarter ended June 30, 2024

Change in Directorate

Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended September 30, 2024

Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended December 31, 2024

Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended March 31, 2025

Outcome of Board Meeting dated July 09, 2025

Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended June 30, 2025

Outcome of Board Meeting dated August 08, 2025

Change in Directorate

Intimation under Reg 30 of SEBI (LODR), 2015

https://valiantlabs.in/wp-content/uploads/2025/07/3.-Announcement-under-Regulation-30-LODR-Raising-of-Funds.pdf

Contact Details Of KMP Under Regulation 30(5) of SEBI (LODR) Regulations, 2015

Outcome of the Rights Issue Committee Meeting held on July 15, 2025

Announcement under Regulation 30 (LODR)-Newspaper Publication

Allotment of Equity Shares on Rights Basis

Contact Information

Authorised Persons

Determining Materiality

Pursuant to regulation 30(5) of the SEBI (Listing Obligation & Disclosure Requirements), Regulations 2015,the following are “severally” authorized for the purpose of determining materiality of an event or information and for the purpose of making disclosures to Stock Exchanges (s).
:

Mr. Santosh Vora (Managing Director)

Mr. Paresh Shah (Executive Director & CFO)

104, Udyog Kshetra | First Floor, Mulund Goregaon Link Road, Mulund (W) – 400080

Disclosure Submission

Mr. Akshay Gangurde
Company Secretary & Compliance Officer
Email: complianceofficer@valiantlabs.in

022 – 49712001 / 49717220

investor@valiantlabs.in

Shareholder Grievance and Nodal Officer

Pursuant to regulation 46(2) (j) (k) of the SEBI (Listing Obligation & Disclosure Requirements), Regulations 2015, the investors may contact the below mentioned email id for the purpose of Registering Complaints:
Mr. Akshay Gangurde
Company Secretary & Compliance Officer
Email: complianceofficer@valiantlabs.in

 

 

Registrar and Share Transfer Agent

Pursuant to Regulation 7 of the SEBI (Listing Obligation & Disclosure Requirements), Regulations 2015, the investors may contact the below mentioned Registrar and Share Transfer Agent:

MUFG Intime India Pvt. Ltd.
(Formerly Known as Link Intime India Pvt. Ltd.)
Unit: Valiant Laboratories Limited
C-101, 247 Park, L.B.S. Marg,
Vikhroli (West), Mumbai – 400 083
Phone: +91 22 4918 6000
Fax: +91 22 4918 6060
Email: rnt.helpdesk@in.mpms.mufg.com
Website: www.in.mpms.mufg.com